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other words. We do this by comparing
the network’s activations on the orig-
inal input to its activations when
removing individual words. The
resulting differences in activations
show the interaction between different
words of the input in different layers.
The interactive tool we built allows
users to enter a baseline input and
directly perturbate this input by
excluding words and observing the
influence on activations through all
layers of the network including the
model’s predictive output.
Figure 1 shows how the initial removal
of a single noun affects the processing
of the activations belonging to all other
words. The words most strongly influ-
enced are those that have a linguistic
relationship with the removed word,
like a preposition referencing a noun.
Similarly, we analysed (amongst other
perturbations) the effect of changing the
word order in the source or target sen-
tences revealing the impact of posi-
tional characteristics.
State-of-the-art models for many nat-
ural language processing tasks are arti-
ficial neural networks which are widely
considered to be black box models.
Improvements are often the result of
untargeted parameter sweeps and archi-
tectural modifications. In order to effi-
ciently and systematically improve
such models a deeper understanding of
their inner workings is needed. We
argue that interactive exploration
through input perturbation is a prom-
ising and versatile approach for
inspecting neural networks’ decision
processes and finding specific target
areas for improvement.
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Neurodegenerative diseases such as
Alzheimer’s and Parkinson’s impact
millions of people worldwide. Early
diagnosis has proven to greatly increase
the chances of slowing the diseases’
progression [2]. Correct diagnosis often
relies on the analysis of large amounts
of patient data, and thus lends itself well
to support from machine learning algo-
rithms, which are able to learn from past
diagnosis and see clearly through the
complex interactions of a patient’s
symptoms. Unfortunately, many con-
temporary machine learning techniques
fail to reveal details about how they
reach their conclusions, a property con-
sidered fundamental when providing a
diagnosis. This is one reason why we
introduce our personalisable CDSS that
provides a clear insight into the decision
making process on top of the diagnosis.
Our algorithm enriches the fundamental
work of Masheyekhi and Gras [1]  in
data integration, personal medicine,
usability, visualisation and interactivity. 
Our algorithm performs by extracting a
rule set from a random forest, which is
then minimised within several steps.
The algorithm can be divided into three
major steps. (1) Firstly, a random
forest, an ensemble of decision trees, is
created as the foundation of the algo-
rithm. (2) Secondly, a set of rules is
extracted from the random forest. (3)
Thirdly, this rule set is reduced signifi-
cantly. The user can influence step (3)
by preferring as important considered
features. The algorithm is implemented
in Python and we trained it to predict
whether patients are likely to suffer
from Alzheimer’s or Parkinson’s dis-
ease, but it is a generic algorithm that
can be applied to any kind of disease.
Three main factors are taken into
account during the reduction process:
(a) the performance of individual rules,
(b) the rules’ transparency, and (c) the
personal preferences of the user. The
reduction leads to a new, smaller set of
rules, with predictive performance
comparable to the original set, but
much easier to comprehend. A clear
understanding of the process behind a
diagnosis is crucial for both doctor and
patient, and it is hoped that systems like
this one will become increasingly
prevalent as we continue to improve the
state-of-the art in predictive medicine.
Mashayekhi and Gras [1] introduced
two methods called RF+HC and
RF+HC_CMPR which allow to extract
a rule set from random forests. The
main idea of their work is to reduce the
number of rules dramatically and there-
fore increase the comprehensibility of
the underlying model. We expanded
this idea and added another personalis-
able layer to it to allow the user to add
data driven and personal evidence to
the algorithm.
We applied our algorithm to different
data sets with a variety of data types
like magnetic resonance images, bio-
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We introduce a Clinical Decision Support System (CDSS) as an operation of translational medicine. It
is based on random forests, is personalisable and allows a clear insight into the decision making
process. A well-structured rule set is created and every rule of the decision making process can be
observed by the user (physician). Furthermore, the user has an impact on the creation of the final rule
set and the algorithm allows the comparison of different diseases as well as regional differences in
the same disease.
medical voice measurements, draw-
ings, demographic characteristics, etc.
After the rule set is extracted from the
forest, each rule is assigned with a
score. This score depends on the rule’s
length, its performance on the training
set, and whether it contains any pre-
ferred features. Based on this score, the
weakest rules are eliminated to min-
imise the rule set. The application to
Alzheimer’s and Parkinson’s data sets
has shown that the reduction of the rule
set combined with the consideration of
preferred features, does not generally
impair the performance. It sometimes
even has a positive impact on the pre-
diction, as setting preferred features
can diminish the risk of over-fitting and
take regional characteristics and
expertise into account. Furthermore, a
deliberately reduced set of rules is less
likely to contain noisy rules [1]. The
algorithm also reveals information
about the importance of features, which
allows to draw conclusions about dis-
eases and their indicators. We achieved
accuracies of up to 100% and one rule
set could be reduced to 0.5% of the
original rule set size without reducing
its performance, e.g.
A graphical user interface allows the
algorithm to be used easily, where data
of a new patient can be added intu-
itively. Furthermore, all rules can be
inspected by the physicians. It is also
possible to show statistical distribu-
tions to get a better understanding of
which features are more or less impor-
tant in the decision making process. It
allows to compare different diseases
and detect regional differences like
urban characteristics versus rural ones
or international variations in diseases.
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Special Theme: Transparency in Algorithmic Decision Making
Figure 1: A visual overview of the algorithm.
In healthcare, trust is the basis of the
doctor-patient relationship. A patient
expects the doctor to act reliably and
with precision and to explain options and
decisions. The same accuracy and trans-
parency should be expected of computa-
tional systems redefining the workflow
in healthcare. Since such systems have
inherent uncertainties, it is imperative to
understand a) the reasoning behind such
decisions and b) why mistakes occur.
Anything short of this transparency will
adversely affect the fabric of trust in
these systems and consequently impact
the doctor-patient relationship. 
Current solutions for transparency in
deep learning (used synonymously with
AI) centre around the generation of heat-
maps. These highlight high-impact
image regions on deep learning deci-
sions. While informative in nature,
direct adaptation of such methods into
healthcare is insufficient, because the
actual reasoning patterns remain opaque
and leave a lot of room for guesswork.
Here, deep generative networks show
promise by generating visual clues as to
why a decision was made [1].
We believe transparency in image based
algorithmic decision making can only
be achieved if expert computer scien-
tists and healthcare professionals (radi-
ologists, pathologists etc.) closely col-
laborate in an equal-share environment.
Putting Trust first in the Translation 
of AI for healthcare
by Anirban Mukhopadhyay, David Kügler (TU Darmstadt), Andreas Bucher (University Hospital Frankfurt),
Dieter Fellner (Fraunhofer IGD and TU Darmstadt) and Thomas Vogl (University Hospital Frankfurt)
From screening diseases to personalised precision treatments, AI is showing promise in healthcare.
But how comfortable should we feel about giving black box algorithms the power to heal or kill us?
